Pro-Con: Anti-obesity drugs such as glucagon-like peptide-1 receptor agonists should be a first line treatment in Idiopathic Intracranial Hypertension

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Neuro-Ophthalmology
Publication statusAccepted/In press - 5 Nov 2025

Bibliographical note

Not yet published as of 07/01/2026.

Keywords

  • Glucagon-like peptide-1 receptor agonists
  • intracranial pressure
  • obesity
  • polycystic ovarian syndrome
  • pseudotumor cerebri

Cite this